Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/1995
12/13/1995EP0686142A1 Polyamine derivatives as radioprotective agents
12/13/1995EP0686045A1 Excipient stabilization of polypeptides treated with organic solvents
12/13/1995EP0686034A1 Bisacodyl dosage form
12/13/1995EP0686032A1 Use of 2-chloro-1- 4- (2,6-dichlorophenoxy)methyl]-phenyl]methoxy]-4-methoxy-benzene for the selective treatment of enteroviral infections in humans
12/13/1995EP0686025A1 Titanium dioxide dispersions, cosmetic compositions and methods for using the same
12/13/1995EP0686024A1 Thickening mixture based on guar gum or non-ionic cellulose and a cross-linked polymer, and cosmetic or dermatological hair- or skin-care composition containing said mixture
12/13/1995EP0526524B1 Pharmaceutical compositions
12/13/1995EP0521988B1 Device for iontophoretic drug delivery
12/12/1995US5475096 Binding to three-dimensional targets
12/12/1995US5475092 Deliver cytotoxic drugs to specific cell population in targeted fashion
12/12/1995US5475052 Collagen-synthetic polymer matrices prepared using a multiple step reaction
12/12/1995US5475023 Aqueous pharmaceutical formulations of sodium cromoglycate
12/12/1995US5474980 Prolonged release of biologically active somatotropins
12/12/1995US5474979 Nonirritating emulsions for sensitive tissue
12/12/1995US5474978 Insulin analog formulations
12/12/1995US5474780 Monolithic maleic anhydride drug delivery systems
12/12/1995US5474779 Compositions for aiding in the regeneration of tissue with a prolonged immunomodulating effect
12/12/1995US5474771 Inhibits T cell activation of B cells ; binds to epitope
12/12/1995US5474768 Vaginal tissue moisturizing composition and method
12/12/1995US5474767 Polyamines and method for preparation thereof
12/12/1995US5474765 Drug delivery; heparin/steroid conjugates; selectively hydrolyzable linkage e.g, an acid labile or enzyme-sensitive bond; angiogenesis inhibitors; anticarcinogenic,-arthritic and diabetic agents
12/12/1995US5474764 Alkaline ophthalmic suspensions
12/12/1995US5474760 Method of inhibiting oxidants using alkylaryl polyether alcohol polymers
12/12/1995US5474759 Non-chlorofluorocarbon aerosol formulations
12/12/1995US5474718 Starch hydrolysates as sequesterers
12/12/1995CA2010692C Gelatin capsules containing ranitidine
12/07/1995WO1995033061A1 Method for introducing nucleic acid in higher eukaryotic cells
12/07/1995WO1995032992A1 Synthetic peptide analogs of lung surfactant protein sp-c
12/07/1995WO1995032985A1 3'-(4'-) nonradioactively tagged nucleosides and nucleotides with aminocarboxylic acid, peptide or carboxylic acid spacer
12/07/1995WO1995032741A1 Bile acid conjugates, derivatives thereof with metal complexes and related uses
12/07/1995WO1995032739A1 Cyclodextrin cellular delivery system for oligonucleotides
12/07/1995WO1995032738A1 Modification of clostridial toxins for use as transport proteins
12/07/1995WO1995032737A1 Pharmaceutical composition
12/07/1995WO1995032735A2 Inverse skewing of the lymphocyte repertoire for therapy and prevention of disease
12/07/1995WO1995032730A1 A pharmaceutical preparation comprising glucagon
12/07/1995WO1995032726A1 Cyclosporin containing composition and process for the preparation thereof
12/07/1995DE4419724A1 Lagerstabiles und diffusionsdichtes Mikrokapselwandmaterial A shelf-stable and diffusion-tight microcapsule wall material
12/07/1995DE4418965A1 Transfection of eukaryotic cells with nucleic acid
12/07/1995CA2191777A1 Cyclodextrin cellular delivery system for oligonucleotides
12/07/1995CA2191762A1 Method for introducing nucleic acid in higher eukaryotic cells
12/07/1995CA2191317A1 A pharmaceutical preparation comprising glucagon
12/07/1995CA2190982A1 3'-(4'-) nonradioactively tagged nucleosides and nucleotides with aminocarboxylic acid, peptide or carboxylic acid spacer
12/07/1995CA2190598A1 Pharmaceutical composition
12/06/1995EP0685457A1 Glycerol derivative, device and pharmaceutical composition
12/06/1995EP0685235A1 Extracts of piliostigma thonningii, the use thereof and formulations containing them
12/06/1995EP0685234A1 Drug composition containing nucleic acid copolymer
12/06/1995EP0685232A2 Cefixim formulation
12/06/1995EP0685231A2 Water-dispersible tablet containing lamotrigine
12/06/1995EP0685230A1 Stable dermatologic preparation containing mycophenolic acid
12/06/1995EP0684997A1 Anthrax toxin fusion proteins and uses thereof
12/06/1995EP0684841A1 Protein conjugates, compositions containing them and their applications as medicament
12/06/1995EP0684840A1 Method of preparing colloidal aqueous solutions of active substances which are only slightly soluble in water, and a lipid for use in the method
12/06/1995EP0684839A1 Process for preparing colloidal aqueous solutions of hardly soluble active substances
12/06/1995EP0684814A1 Compositions for oral delivery of active agents
12/06/1995EP0684808A1 Light stable color compositions
12/06/1995EP0684806A1 Transmucosal delivery of macromolecular drugs
12/06/1995EP0673259A4 A method for transplanting cells into the brain and therapeutic uses therefor.
12/06/1995EP0647131B1 Dermatological agent for aiding oxygen transport in the skin
12/06/1995EP0647129B1 Topical application composition
12/06/1995EP0557512B1 Utilization in cosmetic or topical applications of an aqueous dispersion based on organopolysiloxanes and a crosslinked copolymer of acrylamide/neutralized 2-acrylamido 2-methylpropane sulfonic acid
12/06/1995EP0490998B1 Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
12/06/1995EP0445255B1 Treatment of conditions and disease
12/06/1995CN1113074A Aqueous composition
12/06/1995CN1112935A Acylierte gamma-cyclodextrine
12/05/1995US5473055 Antitumor agents; better water solubility, side effect reduction
12/05/1995US5472982 Emulsified external treatment composition containing diclofenac sodium
12/05/1995US5472954 Cyclodextrin complexation
12/05/1995US5472950 Compositions containing cobalt hyaluronic acid complex
12/05/1995US5472946 Transdermal penetration enhancers
12/05/1995US5472944 Suppression of megakaryocytopoiesis by neutrophil activating peptide-2
12/05/1995US5472938 Pharmaceutical depot compositions containing hirudin
12/05/1995US5472712 A drug substrate containing an active agent coated with ethyl cellulose being cured at a temperature greater than the glass transition temperature; storage stability, sustained release
12/05/1995US5472711 Controlled release solid oral dosage form
12/05/1995US5472707 High dose ranolazine formulations
12/05/1995US5472706 Dry compositions for preparing submicron emulsions
12/05/1995US5472705 Pharmaceutical composition containing esters of ω-3 polyunsaturated acids and their use in the topical treatment of morbid affections
12/05/1995US5472704 Pharmaceutical controlled-release composition with bioadhesive properties
12/05/1995US5472689 Hair cosmetic composition containing a poly(N-acylalkyleneimine)-organopolysiloxane block or graft copolymer
12/05/1995CA2047903C Calcitonin-containing emulsion for nasal administration
12/05/1995CA2012875C Skin permeation enhancer compositions
12/05/1995CA1337688C Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants
12/02/1995CA2127762A1 Extracts from piliostigma thonningii, the use thereof and formulations containing them
12/01/1995CA2150442A1 Cefixime composition
11/1995
11/30/1995WO1995032003A1 Modified insulin-like growth factors
11/30/1995WO1995032002A1 Covalent microparticle-drug conjugates for biological targeting
11/30/1995WO1995032001A1 Photodynamic conjugates with biocidal properties
11/30/1995WO1995031979A1 Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions
11/30/1995WO1995031978A1 Anti-acne compositions
11/30/1995WO1995031976A1 Transdermal delivery of anti-epileptic drugs
11/30/1995WO1995031971A1 Method for stabilizing duocarmycin derivatives
11/30/1995WO1995031969A1 Pharmaceutical compositions derived from microelmulsion-based gels, method for their preparation and new microemulsion-based gels
11/30/1995WO1995031968A1 Non-steroidal anti-inflammatory ophthalmic suspensions
11/30/1995WO1995031966A1 Antimicrobial oil-in-water emulsions
11/30/1995WO1995031956A1 Antibacterial oil-in-water emulsions
11/30/1995DE4421391C1 Verwendung von Antikörpern gegen T-Zellen zur verlängerten Immunsuppression Use of antibodies against T-cells for prolonged immunosuppression
11/30/1995DE4416001A1 Composite of homogeneous mol. dispersion of cpd. metal oxide matrix
11/30/1995DE4411414C1 Produkt zur enteralen Versorgung mit Fettsäuren und/oder Aminosäuren sowie Verfahren zur Herstellung eines derartigen Produktes Product for enteral supply of fatty acids and / or amino acids, and methods for making such product
11/30/1995CA2191195A1 Photodynamic conjugates with biocidal properties
11/30/1995CA2190869A1 Pharmaceutical compositions derived from microelmulsion-based gels, method for their preparation and new microemulsion-based gels
11/30/1995CA2190752A1 Modified insulin-like growth factors